Abc

Viscoflu 3mg / ml Syrup

Respiratory Affections Treatment; 200ml bottle

PHARMACOTHERAPEUTIC CATEGORY

Mucolytics.

ACTIVE PRINCIPLES

100 ml contain: ambroxol hydrochloride 300 mg.

EXCIPIENTS

Sorbitol, glycerin, methyl para-hydroxybenzoate, propyl para-hydroxybenzoate, raspberry essence, purified water.

INDICATIONS

Treatment of acute respiratory diseases characterized by thick and viscous hypersecretion.

CONTRAINDICATIONS / SECONDARY EFFECTS

Hypersensitivity 'to the active substance or to any of the excipients. Severe hepatic and / or renal disorders. Children under 2 years of age.

DOSAGE

Adults: 10 ml (30 mg) 3 times a day. Children 2 to 5 years: 2.5ml (7.5mg) 3 times a day. Children over 5 years: 5 ml (15 mg) 3 times a day. It is recommended to take the syrup after meals. Do not use for prolonged treatments.

STORAGE

No special storage precautions.

WARNINGS

The drug should be administered with caution in patients with peptic ulcer. Contains sorbitol. The amount of sorbitol contained in this medicinal product may cause a mild laxative effect. The caloric value of sorbitol is 2.6 kcal / g. The product contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which can cause allergic reactions (including delayed type). Mucolytics can induce bronchial obstruction in children younger 'less than 2 years. In fact, the drainage capacity of the bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children younger 'less than 2 years.

INTERACTIONS

The medicine generally does not interfere with other medications.

SIDE EFFECTS

Rarely: tiredness, dry mouth, rhinorrhea, dysuria, headache, gastrointestinal disturbances (heartburn, dyspepsia, constipation, nausea and vomiting), contact dermatitis or other allergic reactions (especially skin rashes). Unknown frequency: bronchial obstruction.

PREGNANCY AND BREASTFEEDING

For ambroxol no clinical data on exposed pregnancies are available. Caution should be exercised when prescribing the medicine to pregnant women. The drug is excreted in breast milk. The use of ambroxol by the mother can 'cause undesirable effects in the infant; therefore a decision must be made whether to discontinue breastfeeding or treatment with the medicinal product.